Company: IMRX
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001790340-25-000104
Chunk: 371

Company: Immuneering Corp
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 371
---
 net of offering expenses) during the six months ended June 30, 2025, and did not sell any shares of Class A common stock under the ATM Program during the six months ended June 30, 2024. During the twelve months ended December 31, 2024, the Company sold 1,318,752 shares of Class A common stock through its ATM Program, at an average price per share of $3.27, for aggregate gross proceeds of $4.5 million ($4.2 million net of offering expenses). As of June 30, 2025, the Company had aggregate gross sales proceeds capacity of $31.3 million remaining under the ATM Program.Issuance costs incurred related to the Sales Agreement are recorded as deferred offering costs and are classified as long-term assets on the balance sheet at June 30, 2025. The Company had approximately $0.4 million of deferred offering costs as of June 30, 2025 and $0.5 million as of December 31, 2024.

Note 8 - Net Loss Per Share Attributable to Common Stockholders

Basic and diluted net loss per share attributable to common stockholders was calculated at June 30, 2025 and June 30, 2024 as follows:Three Months Ended June 30,Six Months Ended June 30,2025202420252024Numerator:Net loss$(14,433,881)$(14,079,927)$(29,480,012)$(28,387,756)Denominator - basic and diluted:Weighted-average common shares outstanding, basic and diluted35,985,87829,653,35535,759,02629,511,856Net loss per share - basic and diluted$(0.40)$(0.47)$(0.82)$(0.96)

17

The following table sets forth the potentially dilutive securities that have been excluded from the calculation of diluted net loss per share because to include them would be anti-dilutive (in common stock equivalent shares) at June 30, 2025 and June 30, 2024:20252024Options to purchase common stock8,405,3726,596,403Total shares of common stock equivalents8,405,3726,596,403

Note 9 – Stock-Based Compensation

During 2015, the Company established the Long Term Incentive Plan (“Incentive Plan”), under which incentive stock options